Avance Clinical CEO Joins Global BioPharma Panel for Evolution Europe Summit 2023
Avance Clinical CEO, Yvonne Lungershausen has been invited to share the Australian and US CRO experience and future projections with a focus on patient centricity and Decentralized Clinical Trials (DCTs) at the Evolution Europe Summit 2023.
- Avance Clinical CEO, Yvonne Lungershausen has been invited to share the Australian and US CRO experience and future projections with a focus on patient centricity and Decentralized Clinical Trials (DCTs) at the Evolution Europe Summit 2023.
- Avance Clinical was recently identified by GlobalData as a global leader in DCT technology.
- The Evolution Summit is an invitation-only, premium forum bringing leading clinical research executives and innovative solution providers.
- https://www.avancecro.com/avance-clinical-north-america-operations/
- For more information about the benefits of running your next study with Avance Clinical contact us: [email protected]